Extracted from this filing and checked against the source text.
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
MeiraGTx Holdings plc entered into Investment Agreement with Sanofi Foreign Participations B.V. valued at 4,000,000 ordinary shares at $7.50 per share for gross proceeds of $30.0 million (effective 2023-10-30).
- Action
- entry
- Agreement
- equity purchase
- Counterparty
- Sanofi Foreign Participations B.V.
- Value
- 4,000,000 ordinary shares at $7.50 per share for gross proceeds of $30.0 million
- Effective
- 2023-10-30
Exact text from the filing
On October 30, 2023 (the “Closing Date”), MeiraGTx Holdings plc (the “Company”) entered into an Investment Agreement (the “Investment Agreement”) with Sanofi Foreign Participations B.V. (the “Investor”), a wholly-owned subsidiary of Sanofi, and solely for the limited purposes set forth therein, Sanofi (the “Parent”), pursuant to which, among other things and subject to the terms and conditions specified therein, the Company issued an aggregate of 4,000,000 ordinary shares, nominal value $0.00003881 (the “Shares”), at a purchase price of $7.50 per share (the “Private Placement”) for gross proceeds of $30.0 million.
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
MeiraGTx Holdings plc entered into Registration Rights Agreement with Sanofi Foreign Participations B.V. valued at Company obligated to file registration statement to register Shares for resale on or prior to April (effective 2023-10-30).
- Action
- entry
- Agreement
- equity purchase
- Counterparty
- Sanofi Foreign Participations B.V.
- Value
- Company obligated to file registration statement to register Shares for resale on or prior to April
- Effective
- 2023-10-30
Exact text from the filing
In connection with the Private Placement, the Company also entered into a Registration Rights Agreement (the “Registration Rights Agreement”) with the Investor.
View on SEC.gov